Literature DB >> 15087615

Does the use of electroencephalographic bispectral index or auditory evoked potential index monitoring facilitate recovery after desflurane anesthesia in the ambulatory setting?

Paul F White1, Hong Ma, Jun Tang, Ronald H Wender, Alexander Sloninsky, Robert Kariger.   

Abstract

BACKGROUND: Analogous to the Bispectral Index (BIS) monitor, the auditory evoked potential monitor provides an electroencephalographic-derived index (AAI), which is alleged to correlate with the central nervous system depressant effects of anesthetic drugs. This clinical study was designed to test the hypothesis that intraoperative cerebral monitoring guided by either the BIS or the AAI value would facilitate recovery from general anesthesia compared with standard clinical monitoring practices alone in the ambulatory setting.
METHODS: Sixty consenting outpatients undergoing gynecologic laparoscopic surgery were randomly assigned to one of three study groups: (1) control (standard practice), (2) BIS guided, or (3) AAI guided. Anesthesia was induced with 1.5-2.5 mg/kg propofol and 1-1.5 microg/kg fentanyl given intravenously. Desflurane, 3%, in combination with 60% nitrous oxide in oxygen was administered for maintenance of general anesthesia. In the control group, the inspired desflurane concentration was varied based on standard clinical signs. In the BIS- and AAI-guided groups, the inspired desflurane concentrations were titrated to maintain BIS and AAI values in targeted ranges of 50-60 and 15-25, respectively. BIS and AAI values, hemodynamic variables, and the end-tidal desflurane concentration were recorded at 5-min intervals during the maintenance period. The emergence times and recovery times to achieve specific clinical endpoints were recorded at 1- to 10-min intervals. The White fast-track and modified Aldrete recovery scores were assessed on arrival in the PACU, and the quality of recovery score was evaluated at the time of discharge home.
RESULTS: A positive correlation was found between the AAI and BIS values during the maintenance period. The average BIS and AAI values (mean +/- SD) during the maintenance period were significantly lower in the control group (BIS, 41 +/- 10; AAI, 11 +/- 6) compared with the BIS-guided (BIS, 57 +/- 14; AAI, +/- 11) and AAI-guided (BIS, 55 +/- 12; AAI, 20 +/- 10) groups. The end-tidal desflurane concentration was significantly reduced in the BIS-guided (2.7 +/- 0.9%) and AAI-guided (2.6 +/- 0.9%) groups compared with the control group (3.6 +/- 1.5%). The awakening (eye-opening) and discharge times were significantly shorter in the BIS-guided (7 +/- 3 and 132 +/- 39 min, respectively) and AAI-guided (6 +/- 2 and 128 +/- 39 min, respectively) groups compared with the control group (9 +/- 4 and 195 +/- 57 min, respectively). More importantly, the median [range] quality of recovery scores was significantly higher in the BIS-guided (18 [17-18]) and AAI-guided (18 [17-18]) groups when compared with the control group (16 [10-18]).
CONCLUSION: Compared with standard anesthesia monitoring practice, adjunctive use of auditory evoked potential and BIS monitoring can improve titration of desflurane during general anesthesia, leading to an improved recovery profile after ambulatory surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087615     DOI: 10.1097/00000542-200404000-00010

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  15 in total

Review 1.  [Measurement of the depth of anaesthesia].

Authors:  G N Schmidt; J Müller; P Bischoff
Journal:  Anaesthesist       Date:  2008-01       Impact factor: 1.041

2.  Evaluation of the SEDline to improve the safety and efficiency of conscious sedation.

Authors:  Thomas D Caputo; Michael A E Ramsay; Jeffrey A Rossmann; M Miles Beach; Garth R Griffiths; Benjamin Meyrat; James B Barnes; David G Kerns; Brad Crump; Barnett Bookatz; Paul Ezzo
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-07

3.  Effects of A-line Autoregression Index (AAI) monitoring on recovery after sevoflurane anesthesia for bariatric surgery.

Authors:  Ulderico Freo; Michele Carron; Federico Innocente; Mirto Foletto; Donato Nitti; Carlo Ori
Journal:  Obes Surg       Date:  2011-07       Impact factor: 4.129

Review 4.  Bispectral index for improving anaesthetic delivery and postoperative recovery.

Authors:  Yodying Punjasawadwong; Aram Phongchiewboon; Nutchanart Bunchungmongkol
Journal:  Cochrane Database Syst Rev       Date:  2014-06-17

Review 5.  [Anesthesia in ambulatory patients].

Authors:  R Heller; U Nollert; E Entholzner
Journal:  Anaesthesist       Date:  2009-04       Impact factor: 1.041

6.  The Effects of Bispectral Index and Neuromuscular Blockade Monitoring on the Depth of Anaesthesia and Recovery in Cardiac Patients Under Desflurane Anaesthesia.

Authors:  Ayşe Payas; Kenan Kaygusuz; Cevdet Düger; Ahmet Cemil İsbir; İclal Özdemir Kol; Sinan Gürsoy; Caner Mimaroğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2013-06-14

Review 7.  Anaesthetic interventions for prevention of awareness during surgery.

Authors:  Anthony G Messina; Michael Wang; Marshall J Ward; Chase C Wilker; Brett B Smith; Daniel P Vezina; Nathan Leon Pace
Journal:  Cochrane Database Syst Rev       Date:  2016-10-18

Review 8.  Electroencephalogram-based pharmacodynamic measures: a review.

Authors:  Michael Bewernitz; Hartmut Derendorf
Journal:  Int J Clin Pharmacol Ther       Date:  2012-03       Impact factor: 1.366

9.  Bispectral index for improving intraoperative awareness and early postoperative recovery in adults.

Authors:  Sharon R Lewis; Michael W Pritchard; Lizzy J Fawcett; Yodying Punjasawadwong
Journal:  Cochrane Database Syst Rev       Date:  2019-09-26

10.  Bispectral index-guided general anaesthesia in combination with interscalene block reduces desflurane consumption in arthroscopic shoulder surgery: a clinical comparison of bupivacaine versus levobupivacaine.

Authors:  Levent Ozturk; Elvin Kesimci; Tuna Albayrak; Orhan Kanbak
Journal:  BMC Anesthesiol       Date:  2015-07-21       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.